미생물학회지 (Korean Journal of Microbiology)

  • 제52권4호
  • /
  • Pages.482-486
  • /
  • 2016
  • /
  • 0440-2413(pISSN)
  • /
  • 2383-9902(eISSN)
한국미생물학회 (The Microbiological Society of Korea)
권호 표지
DOI QR코드

DOI QR Code

Inonotus obliquus (차가버섯) 추출물의 EBV 양성 인간위암에 대한 in vivo 항종양 효능 연구

Anti-tumor effect of Inonotus obliquus in xenograft animals with EBV+human gastric carcinoma

  • 이슬기 (덕성여자대학교 약학대학) ;
  • 조효선 (덕성여자대학교 약학대학)
  • Lee, Seulki (College of Pharmacy, Duksung Women's University) ;
  • Cho, Hyosun (College of Pharmacy, Duksung Women's University)
  • 투고 : 2016.09.12
  • 심사 : 2016.10.19
  • 발행 : 2016.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

차가버섯(Inonotus obliquus)은 다양한 생리활성을 가진 약용버섯으로 항암, 항산화, 항염효능 등을 가진 것으로 보고되었다. EBV 양성 위암은 EBV관련 암 중 가장 빈번하게 나타나는 형태로 EBV 잠복감염이 그 원인이다. 본 연구에서는 차가버섯 주정추출물의 경구투여를 통해 EBV 양성 인간위암(SNU719) 세포주를 면역결핍 쥐에 주입 후 생기는 고형암 생성억제에 대한 효능을 연구하였다. 또한, 실험종료 후, 각각의 종양조직을 절제하여 항종양 억제기전을 탐구하였다. In vivo 종양생성억제 실험에서 차가버섯은 유의적으로 고형암 생성억제 효능을 보였다. 차가버섯이 투여된 동물유래 종양조직에서 세포자멸사와 관련된 p53, p21 및 Bax의 발현이 크게 증가하였으며, 이는 cleaved caspase-9와 cleaved Parp 발현의 상승과 동반하여 항종양 효능이 세포자멸사를 통해 나타남을 제시하였다. 또한, 이러한 항종양 효능은 세포주 내 잠복되어 있는 EBV 바이러스 유전자인 BZLF-1 및 LMP-2의 발현에도 영향을 미치는 것으로 밝혀졌다.

Inonotus obliquus is a medicinal mushroom with a variety of biological activities. It has reported to have strong anti-cancer, antioxidant and anti-inflammatory properties. EBV+ gastric carcinoma is one of the most common EBV-associated cancers that were caused by latent EBV infection. In this study, we investigated the anti-cancer effects of ethanol extract of I. obliquus using in vivo xenograft animal models implanted with EBV+ human gastric carcinoma (SNU719). We also explored the molecular mechanisms responsible for its anti-cancer activity. The result indicated that the extract of I. obliquus had an anti-cancer effect in in vivo xenograft mice with EBV+ gastric carcinoma (SNU719). Extract of I. obliquus also showed a great effect on inducing the expression of p53, p21 and Bax in tumor tissue derived from EBV+ human gastric carcinoma, and these were correlated with increased expressions of the cleaved forms of caspase-9 and Parp. Also, I. obliquus attenuated the expression of viral proteins, BZLF-1 and LMP-2 in tumor tissue from EBV+ human gastric carcinoma.

키워드

참고문헌

  1. Choi, S.Y., Hur, S.J., An, C.S., Jeon, Y.H., Jeoung, Y.J., Bak, J.P., and Lim, B.O. 2010. Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate. J. Biomed. Biotechnol. 2010, 943516.
  2. Chung, M.J., Chung, C.K., Jeong, Y., and Ham, S.S. 2010. Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. Nutr. Res. Pract. 4, 177-182. https://doi.org/10.4162/nrp.2010.4.3.177
  3. Cui, Y., Kim, D.S., and Park, K.C. 2005. Antioxidant effect of Inonotus obliquus. J. Ethnopharmacol. 96, 79-85. https://doi.org/10.1016/j.jep.2004.08.037
  4. Kim, Y.O., Park, H.W., Kim, J.H., Lee, J.Y., Moon, S.H., and Shin, C.S. 2006. Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci. 79, 72-80. https://doi.org/10.1016/j.lfs.2005.12.047
  5. Koh, D.W., Dawson, T.M., and Dawson, V.L. 2005. Mediation of cell death by poly (ADP-ribose) polymerase-1. Pharmacol. Res. 52, 5-14. https://doi.org/10.1016/j.phrs.2005.02.011
  6. Lee, S., Lee, H.H., Kim, J., Jung, J., Moon, A., Jeong, C.S., Kang, H., and Cho, H. 2015a. Anti-tumor effect of Cordyceps militaris in HCV-infected human hepatocarcinoma 7.5 cells. J. Microbiol. 53, 468-474. https://doi.org/10.1007/s12275-015-5198-x
  7. Lee, H.H., Lee, S., Lee, K., Shin, Y.S., Kang, H., and Cho, H. 2015b. Anti-cancer effect of Cordyceps militaris in human colorectal carcinoma RKO cells via cell cycle arrest and mitochondrial apoptosis. Daru. 23, 35. https://doi.org/10.1186/s40199-015-0117-6
  8. Lee, M., Son, M., Ryu, E., Shin, Y.S., Kim, J.G., Kang, B.W., Cho, H., and Kang, H. 2015c. Quercetin-induced apoptosis prevents EBV infection. Oncotarget. 6, 12603-12624. https://doi.org/10.18632/oncotarget.3687
  9. Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., and Gu, W. 2012. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 149, 1269-1283. https://doi.org/10.1016/j.cell.2012.04.026
  10. Matt, S. and Hofmann, T.G. 2016. The DNA damage-induced cell death response: A roadmap to kill cancer cells. Cell. Mol. Life Sci. 73, 2829-2850. https://doi.org/10.1007/s00018-016-2130-4
  11. Nakata, T., Yamada, T., Taji, S., Ohishi, H., Wada, S., Tokuda, H., Sakuma, K., and Tanaka, R. 2007. Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. Bioorg. Med. Chem. 15, 257-264. https://doi.org/10.1016/j.bmc.2006.09.064
  12. Nishikawa, J., Yoshiyama, H., Iizasa, H., Kanehiro, Y., Nakamura, M., Nishimura, J., Saito, M., Okamoto, T., Sakai, K., Suehiro, Y., et al. 2014. Epstein-Barr virus in gastric carcinoma. Cancers (Basel). 6, 2259-2274. https://doi.org/10.3390/cancers6042259
  13. Nomura, M., Takahashi, T., Uesugi, A., Tanaka, R., and Kobayashi, S. 2008. Inotodiol, a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis. Anticancer Res. 28, 2691-2696.
  14. Saar, M. 1991. Fungi in Khanty folk medicine. J. Ethnopharmacol. 31, 175-179. https://doi.org/10.1016/0378-8741(91)90003-V
  15. Shibnev, V.A., Mishin, D.V., Garaev, T.M., Finogenova, N.P., Botikov, A.G., and Deryabin, P.G. 2011. Antiviral activity of Inonotus obliquus fungus extract towards infection caused by hepatitis C virus in cell cultures. Bull. Exp. Biol. Med. 151, 612-614. https://doi.org/10.1007/s10517-011-1395-8
  16. Taji, S., Yamada, T., Wada, S., Tokuda, H., Sakuma, K., and Tanaka, R. 2008. Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity. Eur. J. Med. Chem. 43, 2373-2379. https://doi.org/10.1016/j.ejmech.2008.01.037
  17. Tokunaga, M., Land, C.E., Uemura, Y., Tokudome, T., Tanaka, S., and Sato, E. 1993. Epstein-Barr Virus in gastric carcinoma. Am. J. Pathol. 143, 1250-1254.
  18. Wasser, S.P. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biotechnol. 60, 258-274. https://doi.org/10.1007/s00253-002-1076-7
  19. Young, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K.C., Ritz, J., Shapiro, R.S., Rickinson, A., Kieff, E., et al. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321, 1080-1085. https://doi.org/10.1056/NEJM198910193211604
  20. Young, L.S. and Rickinson, A.B. 2004. Epstein-barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768. https://doi.org/10.1038/nrc1452
  21. Zhong, X.H., Wang, L.B., and Sun, D.Z. 2011. Effects of inotodiol extracts from Inonotus obliquus on proliferation cycle and apoptotic gene of human lung adenocarcinoma cell line A549. Chin. J. Integr. Med. 17, 218-223. https://doi.org/10.1007/s11655-011-0670-x